1. Home
  2. AIMD vs AMBO Comparison

AIMD vs AMBO Comparison

Compare AIMD & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • AMBO
  • Stock Information
  • Founded
  • AIMD 1984
  • AMBO 2000
  • Country
  • AIMD United States
  • AMBO United States
  • Employees
  • AIMD N/A
  • AMBO N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • AMBO Other Consumer Services
  • Sector
  • AIMD Health Care
  • AMBO Real Estate
  • Exchange
  • AIMD Nasdaq
  • AMBO Nasdaq
  • Market Cap
  • AIMD 8.2M
  • AMBO 8.8M
  • IPO Year
  • AIMD N/A
  • AMBO 2010
  • Fundamental
  • Price
  • AIMD $0.54
  • AMBO $3.19
  • Analyst Decision
  • AIMD
  • AMBO
  • Analyst Count
  • AIMD 0
  • AMBO 0
  • Target Price
  • AIMD N/A
  • AMBO N/A
  • AVG Volume (30 Days)
  • AIMD 168.9K
  • AMBO 27.3K
  • Earning Date
  • AIMD 05-12-2025
  • AMBO 12-30-2024
  • Dividend Yield
  • AIMD N/A
  • AMBO N/A
  • EPS Growth
  • AIMD N/A
  • AMBO N/A
  • EPS
  • AIMD N/A
  • AMBO 0.11
  • Revenue
  • AIMD $20,729.00
  • AMBO $9,392,000.00
  • Revenue This Year
  • AIMD N/A
  • AMBO N/A
  • Revenue Next Year
  • AIMD N/A
  • AMBO N/A
  • P/E Ratio
  • AIMD N/A
  • AMBO $28.89
  • Revenue Growth
  • AIMD N/A
  • AMBO 2.50
  • 52 Week Low
  • AIMD $0.40
  • AMBO $1.00
  • 52 Week High
  • AIMD $1.46
  • AMBO $5.55
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 50.95
  • AMBO 59.88
  • Support Level
  • AIMD $0.51
  • AMBO $3.02
  • Resistance Level
  • AIMD $0.57
  • AMBO $3.39
  • Average True Range (ATR)
  • AIMD 0.04
  • AMBO 0.32
  • MACD
  • AIMD -0.00
  • AMBO 0.01
  • Stochastic Oscillator
  • AIMD 36.71
  • AMBO 64.37

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

Share on Social Networks: